首页> 外文期刊>Journal of refractive surgery >Outcome of LASIK for myopia in women on hormone replacement therapy.
【24h】

Outcome of LASIK for myopia in women on hormone replacement therapy.

机译:激素替代疗法在女性近视中的LASIK结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: To investigate the effect of hormone treatment on refractive and visual outcome after LASIK in women. METHODS: A retrospective review of the hospital notes of all women on hormone replacement therapy (HRT) and oral contraceptives at the time of LASIK was performed. Their refractive and visual outcomes were compared with those of women not on hormone treatment. RESULTS: At 6 months after LASIK, 20 (45%) HRT eyes and 61 (75%) control eyes had a visual acuity of > or = 20/20. Thirty-six (82%) eyes from the HRT group and 74 (91%) eyes from the control group could see > or = 20/40. A statistically significant difference was noted in both refractive and visual outcome in women taking HRT at the time of surgery in comparison to controls. Women on the oral contraceptive pill did not differ in outcome from controls. CONCLUSIONS: Women on HRT are at an increased risk of refractive regression after LASIK.
机译:目的:探讨激素治疗对女性LASIK术后屈光和视觉结果的影响。方法:对LASIK手术时所有接受激素替代疗法(HRT)和口服避孕药的妇女的医院笔记进行回顾性回顾。他们的屈光和视觉结果与未接受激素治疗的女性相比。结果:LASIK术后6个月,HRT眼为20(45%),对照眼为61(75%),视力≥20/20。 HRT组的三十六(82%)眼和对照组的74(91%)眼可以看到>或= 20/40。与对照组相比,在手术时接受HRT的女性在屈光和视觉结局方面均存在统计学上的显着差异。口服避孕药的妇女的结局与对照组无差异。结论:接受HRT治疗的女性在LASIK术后屈光退化的风险增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号